Clearlake Capital Group and Charlesbank Capital Partners-backed Symplr, an enterprise healthcare operations and SaaS services provider, has completed its acquisition of Midas Health Analytics Solutions. The deal was previously announced on January 4th, 2021.
The deal is intended to strengthen Symplr’s SaaS-based GRC portfolio. Midas will enhance Symplr’s capabilities in improving patient safety and outcomes through its portfolio of safety and advanced analytics software services.
“The Midas acquisition is complementary with Symplr’s existing GRC portfolio, and ensures our customers achieve the clinical, operational, and financial targets necessary for success in the world of value-based care,” commented BJ Schaknowski, CEO of Symplr. “This acquisition aligns with our mission to provide solutions that support a more efficient and better-serving healthcare system for patients, providers, payers, administrators, and staff of today and tomorrow.”
“Midas is a natural complement to Symplr’s existing compliance, quality, and safety solutions,” stated Ryan Carroll, managing director of Charlesbank. “Now, Symplr customers can track and trend quality performance over time, proactively manage and mitigate risk, and make data-driven decisions amid constant regulatory change to create a safe care environment.”